Allurion Technologies Inc. (NYSE:ALUR – Get Free Report) was the target of a large decline in short interest during the month of January. As of January 15th, there was short interest totalling 46,700 shares, a decline of 95.6% from the December 31st total of 1,060,000 shares. Approximately 2.4% of the company’s stock are sold short. Based on an average daily volume of 27,600 shares, the short-interest ratio is currently 1.7 days.
Wall Street Analysts Forecast Growth
ALUR has been the subject of several analyst reports. Chardan Capital cut Allurion Technologies from a “buy” rating to a “neutral” rating in a research report on Thursday, November 14th. TD Cowen started coverage on Allurion Technologies in a report on Wednesday, October 2nd. They issued a “buy” rating and a $50.00 price target for the company. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Allurion Technologies has an average rating of “Buy” and an average target price of $71.88.
Read Our Latest Report on ALUR
Institutional Investors Weigh In On Allurion Technologies
Allurion Technologies Stock Performance
Allurion Technologies stock opened at $5.38 on Wednesday. The company has a market capitalization of $13.94 million, a P/E ratio of -0.45 and a beta of -0.62. Allurion Technologies has a fifty-two week low of $2.37 and a fifty-two week high of $98.75. The stock has a 50-day simple moving average of $7.97 and a 200-day simple moving average of $14.18.
About Allurion Technologies
Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
Featured Stories
- Five stocks we like better than Allurion Technologies
- Dividend Payout Ratio Calculator
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How to Capture the Benefits of Dividend Increases
- What Does the Future Hold for Eli Lilly?
- The How and Why of Investing in Gold Stocks
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.